Title: | Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness |
Journal : | Neuropsychiatric disease and treatment, 14 |
Authors: | Omori Y, Author ; Kanbayashi T ; Imanishi A ; Tsutsui K ; Sagawa Y ; Kikuchi YS ; Takeshima M ; Yoshizawa K ; Uemura S ; Shimizu T |
Material Type: | Article |
Publisher: | New Zealand, 2018 |
Size: | p 451 |
General note: |
Erratum in:
Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]. [Neuropsychiatr Dis Treat. 2018] = Corrigendum published online May 22, 2018: "This corrects the article "Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness" on page 451. On page 451, the Result section in the abstract, 2nd sentence reads “There were significant differences in the ESS scores and MSL between decreased and normal CSF orexin groups in DM1 patients” it should have been “Differences of the ESS scores and MSL between decreased and normal CSF orexin groups were insignificant among DM1 patients”." |
Languages: | English |
Keywords : | cerebrospinal fluid ; comparative studies ; daytime somnolence ; Japan ; myotonic dystrophy type 1 ; orexin ; polysomnography ; retrospective studies ; sleep disorders |
Keywords: | muscleblind-like protein;myotonic dystrophy type 1;narcolepsy;orexin;sleep-onset rapid eye movement periods; |
Pubmed / DOI : | DOI : 10.2147/NDT.S158651 / Pubmed : 29445282 |
N° Profil MNM : | 2018022 |
Link for e-copy: | http://www.ncbi.nlm.nih.gov/pubmed/29445282 |